Visionary Holdings (GV), announced that its wholly owned subsidiary, Visionary Health Technology Group, announced the signing of a $12M exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex—President Super Injection, in cooperation with Huajin China Investment Company, alongside the Board-approved divestiture of its non-core education business.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GV:
- Visionary Holdings provides execution update on $9M sales contract
- Visionary Holdings establishes three subsidiaries in Qingdao, Wuxi, Wuhu
- Visionary Holdings regains compliance with Nasdaq periodic filing rule
- Visionary Holdings Overhauls Governance and Seals Key Deals in Pivot to High-End Anti-Aging Aesthetics